This article has been updated to correct an error in the headline.
 
NEW YORK (GenomeWeb News) - JPT Peptide Technologies, a subsidiary of Berlin-based pharmaceutical company Jerini, said today that Mount Sinai School of Medicine will use its PepStar peptide-microarray platform as part of a biomarker discovery collaboration.
 
JPT and MSSM will use the peptide arrays to discover B-cell epitopes for use in developing vaccines and diagnostics in the field of food allergies.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.